Does a partner of a patient with trichomoniasis need treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Partners for Trichomoniasis

Yes, partners of patients with trichomoniasis should always be treated simultaneously to prevent reinfection, even if they are asymptomatic. 1

Rationale for Partner Treatment

  • Trichomoniasis is a sexually transmitted disease that can easily lead to reinfection if partners are not treated
  • The CDC recommends that all sexual partners be treated simultaneously to prevent reinfection 1
  • Partner treatment significantly increases cure rates, which are typically 90-95% with appropriate treatment 2
  • Most men infected with Trichomonas vaginalis are asymptomatic carriers, making them silent reservoirs for reinfection if left untreated 2

Treatment Protocol

  1. First-line treatment for partners:

    • Metronidazole 2g orally in a single dose 1
    • Alternative: Metronidazole 500mg orally twice daily for 7 days 1
  2. For partners with metronidazole allergy:

    • Tinidazole 2g orally in a single dose 1, 3
  3. Patient and partner management:

    • Both patient and partner(s) should be treated simultaneously 2, 1
    • Sexual abstinence until both parties complete treatment and are asymptomatic 1
    • All recent sexual partners (within 60 days) should be evaluated and treated 1

Important Clinical Considerations

  • Partner treatment is essential regardless of whether the partner is symptomatic or not 2, 1
  • Without partner treatment, reinfection is common, leading to treatment failure and persistent infection 4
  • In a study of HIV-infected women with trichomoniasis, patient-delivered partner treatment showed high adherence rates (75.4% provided treatment to all partners) 4
  • The FDA label for tinidazole explicitly states: "Because trichomoniasis is a sexually transmitted disease with potentially serious sequelae, partners of infected patients should be treated simultaneously in order to prevent re-infection" 3

Potential Barriers to Partner Treatment

  • Multiple sex partners
  • Partners unaware of patient's infection status
  • Single relationship status 4

Follow-up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 2
  • Consider retesting all patients 3 months after treatment due to high rates of reinfection 1
  • If symptoms persist, consider treatment failure and re-treat with metronidazole 500mg twice daily for 7 days 1

Cautions

  • Both patient and partner should avoid alcohol during treatment and for 3 days afterward due to potential disulfiram-like reaction 3
  • Topical metronidazole preparations are not effective for trichomoniasis (less than 50% efficacy) and should not be used 1
  • If treatment failure occurs despite partner treatment, consider metronidazole resistance and consult with an expert 1

Partner treatment is a critical component of trichomoniasis management, as it breaks the cycle of reinfection and increases overall cure rates. Without treating partners, the 90-95% cure rate with appropriate treatment will be significantly compromised.

References

Guideline

Treatment of Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.